Clincosm LogoSign in Get a demo

deleterious brca2 gene mutation

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

Active, not recruiting
  • Deleterious BRCA1 Gene Mutation
  • +5 more
  • Behavioral, Psychological or Informational Intervention
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,

Recruiting
  • Deleterious BRCA1 Gene Mutation
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 23, 2022

Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

Active, not recruiting
  • Deleterious BARD1 Gene Mutation
  • +13 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Chicago, Illinois
  • +8 more
Feb 25, 2022

ATM Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial (Epacadostat, Pembrolizumab)

Withdrawn
  • ATM Gene Mutation
  • +9 more
  • (no location specified)
May 28, 2019